Medicare prescription drug cost, prescriptions and prescribers, 2024
Medicare cost, 2024
$56.5M
-36.5% from 2023
Prescriptions
68K
$831.01 per claim
Patients
19K
11,105 prescribers
Total spending, 2024
$56.5M
$2,926.08 per patient
Medicare prescription drug plans paid $56.5M for Repatha Pushtronex in 2024, for 67,989 prescriptions and refills to 19,311 patients (down 36.5% from 2023). The average cost per claim was $831.01.
California had the highest Medicare cost for Repatha Pushtronex in 2024: $8.5M for 10,250 claims, followed by Texas ($5.3M).
Jaesoo Pak, internal medicine in Cerritos, CA, had the highest Medicare cost for Repatha Pushtronex in 2024: 731 claims costing $553K.
Repatha Pushtronex is made by Amgen Inc. (AMGN), listed in the Medicare spending data as Amgen USA Inc..
All plans and makers
Where the prescribers practice, 2024
By Medicare drug cost
| Prescriber | Type | Claims | Patients | Cost |
|---|---|---|---|---|
| Jaesoo Pak Cerritos, CA | Internal Medicine | 731 | 123 | $553K |
| Eddie C Pyune Garden Grove, CA | Family Practice | 664 | 119 | $514K |
| Alexander M Swan |
| Year | Prescribers | Claims | Patients | Cost |
|---|---|---|---|---|
| 2022 | 8,434 | 78,430 | 14,164 | $63.3M |
| 2023 | 10,739 | 100,842 | 18,416 | $89.0M |
| 2024 | 11,105 | 67,989 | 19,311 | $56.5M |
More drugs: top Medicare drugs by cost and the Prescriptions tab.
Official US government data on Medicare prescription drug plans (Part D) and Medicaid drug use. Cost and spending are before the rebates drug makers pay. Prescribers with fewer than 11 claims of the drug are not published.
| Internal Medicine |
| 169 |
| 76 |
| $211K |
| Dustin T Nguyen New York, NY | Internal Medicine | 270 | 43 | $197K |
| Vamsi Krishna Kyle, TX | Interventional Cardiology | 183 | 67 | $180K |
| Paul A Tucker II Austin, TX | Interventional Cardiology | 175 | 74 | $179K |
| Don W Lee Glendale, CA | Interventional Cardiology | 240 | 60 | $157K |
| George G Le-Bert Fernandina Beach, FL | Internal Medicine | 191 | 57 | $141K |
| Peter S Fail Houma, LA | Advanced Heart Failure and Transplant Cardiology | 177 | 44 | $137K |
| Wael Al-Halaseh Fort Payne, AL | Cardiology | 183 | 50 | $124K |
| Nydia M Bladuell Marietta, GA | Interventional Cardiology | 154 | 46 | $117K |
| Mouhanad Freih Lewes, DE | Cardiology | 82 | 46 | $117K |
| Konstantinos Vlachonassios Lakewood, CA | Cardiology | 150 | 35 | $115K |
| Trung Tran Columbia, MO | Interventional Cardiology | 80 | 51 | $110K |
| Benjamin S Citrin Mobile, AL | Cardiology | 117 | 40 | $109K |
| Richard P Abben Houma, LA | Interventional Cardiology | 137 | 40 | $109K |
| Wojciech Mazur Cincinnati, OH | Cardiology | 110 | 40 | $105K |
| Avraham Y Henoch New York, NY | Family Practice | 164 | 27 | $103K |
| Yoon S Pak Cerritos, CA | Family Practice | 132 | 31 | $102K |
| Charles P Bolotte Napoleonville, LA | Family Practice | 78 | 34 | $99K |
| Michelle L Stoudt State College, PA | Cardiology | 133 | 37 | $94K |
| Patricia J Chang Century City, CA | Internal Medicine | 107 | 28 | $92K |
| Waleed Irani Nashville, TN | Cardiology | 98 | 32 | $89K |
| Ashley Lee Pittsburgh, PA | Cardiology | 112 | 30 | $89K |
| Yaqoob Mohyuddin Hazleton, PA | Cardiology | 109 | 30 | $84K |
Spending by manufacturer as listed in the spending data
| Manufacturer | Claims | Spending |
|---|---|---|
| Amgen USA Inc. AMGN | 68,043 | $56.5M |